<?xml version='1.0' encoding='UTF-8'?>
<uniprot xmlns="http://uniprot.org/uniprot" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://uniprot.org/uniprot http://www.uniprot.org/support/docs/uniprot.xsd">
<entry dataset="Swiss-Prot" created="1994-10-01" modified="2017-05-10" version="205">
<accession>P37173</accession>
<accession>B4DTV5</accession>
<accession>Q15580</accession>
<accession>Q6DKT6</accession>
<accession>Q99474</accession>
<name>TGFR2_HUMAN</name>
<protein>
<recommendedName>
<fullName>TGF-beta receptor type-2</fullName>
<shortName>TGFR-2</shortName>
<ecNumber>2.7.11.30</ecNumber>
</recommendedName>
<alternativeName>
<fullName>TGF-beta type II receptor</fullName>
</alternativeName>
<alternativeName>
<fullName>Transforming growth factor-beta receptor type II</fullName>
<shortName>TGF-beta receptor type II</shortName>
<shortName>TbetaR-II</shortName>
</alternativeName>
</protein>
<gene>
<name type="primary">TGFBR2</name>
</gene>
<organism>
<name type="scientific">Homo sapiens</name>
<name type="common">Human</name>
<dbReference type="NCBI Taxonomy" id="9606"/>
<lineage>
<taxon>Eukaryota</taxon>
<taxon>Metazoa</taxon>
<taxon>Chordata</taxon>
<taxon>Craniata</taxon>
<taxon>Vertebrata</taxon>
<taxon>Euteleostomi</taxon>
<taxon>Mammalia</taxon>
<taxon>Eutheria</taxon>
<taxon>Euarchontoglires</taxon>
<taxon>Primates</taxon>
<taxon>Haplorrhini</taxon>
<taxon>Catarrhini</taxon>
<taxon>Hominidae</taxon>
<taxon>Homo</taxon>
</lineage>
</organism>
<reference key="1">
<citation type="journal article" date="1992" name="Cell" volume="68" first="775" last="785">
<title>Expression cloning of the TGF-beta type II receptor, a functional transmembrane serine/threonine kinase.</title>
<authorList>
<person name="Lin H.Y."/>
<person name="Wang X.-F."/>
<person name="Ng-Eaton E."/>
<person name="Weinberg R.A."/>
<person name="Lodish H.F."/>
</authorList>
<dbReference type="PubMed" id="1310899"/>
<dbReference type="DOI" id="10.1016/0092-8674(92)90152-3"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1)</scope>
<scope>VARIANT ALA-439</scope>
<scope>SUBCELLULAR LOCATION</scope>
<source>
<tissue>Liver</tissue>
</source>
</reference>
<reference key="2">
<citation type="journal article" date="1992" name="Cell" volume="70" first="1069" last="1069">
<authorList>
<person name="Lin H.Y."/>
<person name="Wang X.-F."/>
<person name="Ng-Eaton E."/>
<person name="Weinberg R.A."/>
<person name="Lodish H.F."/>
</authorList>
<dbReference type="PubMed" id="1525823"/>
</citation>
<scope>ERRATUM</scope>
</reference>
<reference key="3">
<citation type="journal article" date="1994" name="Gene" volume="149" first="367" last="372">
<title>A cDNA encoding the human transforming growth factor beta receptor suppresses the growth defect of a yeast mutant.</title>
<authorList>
<person name="Nikawa J."/>
</authorList>
<dbReference type="PubMed" id="7959019"/>
<dbReference type="DOI" id="10.1016/0378-1119(94)90178-3"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2)</scope>
<source>
<tissue>Glial cell</tissue>
</source>
</reference>
<reference key="4">
<citation type="journal article" date="1996" name="Genomics" volume="36" first="341" last="344">
<title>The genomic structure of the gene encoding the human transforming growth factor beta type II receptor (TGF-beta RII).</title>
<authorList>
<person name="Takenoshita S."/>
<person name="Hagiwara K."/>
<person name="Nagashima M."/>
<person name="Gemma A."/>
<person name="Bennett W.P."/>
<person name="Harris C.C."/>
</authorList>
<dbReference type="PubMed" id="8812462"/>
<dbReference type="DOI" id="10.1006/geno.1996.0471"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA] (ISOFORM 1)</scope>
<scope>VARIANT ALA-439</scope>
</reference>
<reference key="5">
<citation type="journal article" date="1996" name="Cancer Res." volume="56" first="4595" last="4598">
<title>Genomic structure of the transforming growth factor beta type II receptor gene and its mutations in hereditary nonpolyposis colorectal cancers.</title>
<authorList>
<person name="Lu S.-L."/>
<person name="Zhang W.C."/>
<person name="Akiyama Y."/>
<person name="Nomizu T."/>
<person name="Yuasa Y."/>
</authorList>
<dbReference type="PubMed" id="8840968"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA] (ISOFORM 1)</scope>
<scope>VARIANT ALA-439</scope>
</reference>
<reference key="6">
<citation type="journal article" date="1996" name="Gene" volume="181" first="185" last="190">
<title>Cloning of a cDNA encoding the human transforming growth factor-beta type II receptor: heterogeneity of the mRNA.</title>
<authorList>
<person name="Ogasa H."/>
<person name="Noma T."/>
<person name="Murata H."/>
<person name="Kawai S."/>
<person name="Nakazawa A."/>
</authorList>
<dbReference type="PubMed" id="8973329"/>
<dbReference type="DOI" id="10.1016/S0378-1119(96)00501-X"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1)</scope>
<scope>VARIANT ALA-439</scope>
<source>
<tissue>Liver</tissue>
</source>
</reference>
<reference key="7">
<citation type="submission" date="2004-07" db="EMBL/GenBank/DDBJ databases">
<authorList>
<consortium name="NIEHS SNPs program"/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA]</scope>
<scope>VARIANT VAL-36</scope>
</reference>
<reference key="8">
<citation type="journal article" date="2004" name="Nat. Genet." volume="36" first="40" last="45">
<title>Complete sequencing and characterization of 21,243 full-length human cDNAs.</title>
<authorList>
<person name="Ota T."/>
<person name="Suzuki Y."/>
<person name="Nishikawa T."/>
<person name="Otsuki T."/>
<person name="Sugiyama T."/>
<person name="Irie R."/>
<person name="Wakamatsu A."/>
<person name="Hayashi K."/>
<person name="Sato H."/>
<person name="Nagai K."/>
<person name="Kimura K."/>
<person name="Makita H."/>
<person name="Sekine M."/>
<person name="Obayashi M."/>
<person name="Nishi T."/>
<person name="Shibahara T."/>
<person name="Tanaka T."/>
<person name="Ishii S."/>
<person name="Yamamoto J."/>
<person name="Saito K."/>
<person name="Kawai Y."/>
<person name="Isono Y."/>
<person name="Nakamura Y."/>
<person name="Nagahari K."/>
<person name="Murakami K."/>
<person name="Yasuda T."/>
<person name="Iwayanagi T."/>
<person name="Wagatsuma M."/>
<person name="Shiratori A."/>
<person name="Sudo H."/>
<person name="Hosoiri T."/>
<person name="Kaku Y."/>
<person name="Kodaira H."/>
<person name="Kondo H."/>
<person name="Sugawara M."/>
<person name="Takahashi M."/>
<person name="Kanda K."/>
<person name="Yokoi T."/>
<person name="Furuya T."/>
<person name="Kikkawa E."/>
<person name="Omura Y."/>
<person name="Abe K."/>
<person name="Kamihara K."/>
<person name="Katsuta N."/>
<person name="Sato K."/>
<person name="Tanikawa M."/>
<person name="Yamazaki M."/>
<person name="Ninomiya K."/>
<person name="Ishibashi T."/>
<person name="Yamashita H."/>
<person name="Murakawa K."/>
<person name="Fujimori K."/>
<person name="Tanai H."/>
<person name="Kimata M."/>
<person name="Watanabe M."/>
<person name="Hiraoka S."/>
<person name="Chiba Y."/>
<person name="Ishida S."/>
<person name="Ono Y."/>
<person name="Takiguchi S."/>
<person name="Watanabe S."/>
<person name="Yosida M."/>
<person name="Hotuta T."/>
<person name="Kusano J."/>
<person name="Kanehori K."/>
<person name="Takahashi-Fujii A."/>
<person name="Hara H."/>
<person name="Tanase T.-O."/>
<person name="Nomura Y."/>
<person name="Togiya S."/>
<person name="Komai F."/>
<person name="Hara R."/>
<person name="Takeuchi K."/>
<person name="Arita M."/>
<person name="Imose N."/>
<person name="Musashino K."/>
<person name="Yuuki H."/>
<person name="Oshima A."/>
<person name="Sasaki N."/>
<person name="Aotsuka S."/>
<person name="Yoshikawa Y."/>
<person name="Matsunawa H."/>
<person name="Ichihara T."/>
<person name="Shiohata N."/>
<person name="Sano S."/>
<person name="Moriya S."/>
<person name="Momiyama H."/>
<person name="Satoh N."/>
<person name="Takami S."/>
<person name="Terashima Y."/>
<person name="Suzuki O."/>
<person name="Nakagawa S."/>
<person name="Senoh A."/>
<person name="Mizoguchi H."/>
<person name="Goto Y."/>
<person name="Shimizu F."/>
<person name="Wakebe H."/>
<person name="Hishigaki H."/>
<person name="Watanabe T."/>
<person name="Sugiyama A."/>
<person name="Takemoto M."/>
<person name="Kawakami B."/>
<person name="Yamazaki M."/>
<person name="Watanabe K."/>
<person name="Kumagai A."/>
<person name="Itakura S."/>
<person name="Fukuzumi Y."/>
<person name="Fujimori Y."/>
<person name="Komiyama M."/>
<person name="Tashiro H."/>
<person name="Tanigami A."/>
<person name="Fujiwara T."/>
<person name="Ono T."/>
<person name="Yamada K."/>
<person name="Fujii Y."/>
<person name="Ozaki K."/>
<person name="Hirao M."/>
<person name="Ohmori Y."/>
<person name="Kawabata A."/>
<person name="Hikiji T."/>
<person name="Kobatake N."/>
<person name="Inagaki H."/>
<person name="Ikema Y."/>
<person name="Okamoto S."/>
<person name="Okitani R."/>
<person name="Kawakami T."/>
<person name="Noguchi S."/>
<person name="Itoh T."/>
<person name="Shigeta K."/>
<person name="Senba T."/>
<person name="Matsumura K."/>
<person name="Nakajima Y."/>
<person name="Mizuno T."/>
<person name="Morinaga M."/>
<person name="Sasaki M."/>
<person name="Togashi T."/>
<person name="Oyama M."/>
<person name="Hata H."/>
<person name="Watanabe M."/>
<person name="Komatsu T."/>
<person name="Mizushima-Sugano J."/>
<person name="Satoh T."/>
<person name="Shirai Y."/>
<person name="Takahashi Y."/>
<person name="Nakagawa K."/>
<person name="Okumura K."/>
<person name="Nagase T."/>
<person name="Nomura N."/>
<person name="Kikuchi H."/>
<person name="Masuho Y."/>
<person name="Yamashita R."/>
<person name="Nakai K."/>
<person name="Yada T."/>
<person name="Nakamura Y."/>
<person name="Ohara O."/>
<person name="Isogai T."/>
<person name="Sugano S."/>
</authorList>
<dbReference type="PubMed" id="14702039"/>
<dbReference type="DOI" id="10.1038/ng1285"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2)</scope>
<source>
<tissue>Placenta</tissue>
</source>
</reference>
<reference key="9">
<citation type="submission" date="2005-07" db="EMBL/GenBank/DDBJ databases">
<authorList>
<person name="Mural R.J."/>
<person name="Istrail S."/>
<person name="Sutton G.G."/>
<person name="Florea L."/>
<person name="Halpern A.L."/>
<person name="Mobarry C.M."/>
<person name="Lippert R."/>
<person name="Walenz B."/>
<person name="Shatkay H."/>
<person name="Dew I."/>
<person name="Miller J.R."/>
<person name="Flanigan M.J."/>
<person name="Edwards N.J."/>
<person name="Bolanos R."/>
<person name="Fasulo D."/>
<person name="Halldorsson B.V."/>
<person name="Hannenhalli S."/>
<person name="Turner R."/>
<person name="Yooseph S."/>
<person name="Lu F."/>
<person name="Nusskern D.R."/>
<person name="Shue B.C."/>
<person name="Zheng X.H."/>
<person name="Zhong F."/>
<person name="Delcher A.L."/>
<person name="Huson D.H."/>
<person name="Kravitz S.A."/>
<person name="Mouchard L."/>
<person name="Reinert K."/>
<person name="Remington K.A."/>
<person name="Clark A.G."/>
<person name="Waterman M.S."/>
<person name="Eichler E.E."/>
<person name="Adams M.D."/>
<person name="Hunkapiller M.W."/>
<person name="Myers E.W."/>
<person name="Venter J.C."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]</scope>
</reference>
<reference key="10">
<citation type="journal article" date="2004" name="Protein Sci." volume="13" first="2819" last="2824">
<title>Signal peptide prediction based on analysis of experimentally verified cleavage sites.</title>
<authorList>
<person name="Zhang Z."/>
<person name="Henzel W.J."/>
</authorList>
<dbReference type="PubMed" id="15340161"/>
<dbReference type="DOI" id="10.1110/ps.04682504"/>
</citation>
<scope>PROTEIN SEQUENCE OF 23-37</scope>
</reference>
<reference key="11">
<citation type="journal article" date="1995" name="EMBO J." volume="14" first="2199" last="2208">
<title>GS domain mutations that constitutively activate T beta R-I, the downstream signaling component in the TGF-beta receptor complex.</title>
<authorList>
<person name="Wieser R."/>
<person name="Wrana J.L."/>
<person name="Massague J."/>
</authorList>
<dbReference type="PubMed" id="7774578"/>
</citation>
<scope>FUNCTION IN PHOSPHORYLATION OF TGFBR1</scope>
</reference>
<reference key="12">
<citation type="journal article" date="1998" name="Cell" volume="95" first="779" last="791">
<title>SARA, a FYVE domain protein that recruits Smad2 to the TGFbeta receptor.</title>
<authorList>
<person name="Tsukazaki T."/>
<person name="Chiang T.A."/>
<person name="Davison A.F."/>
<person name="Attisano L."/>
<person name="Wrana J.L."/>
</authorList>
<dbReference type="PubMed" id="9865696"/>
<dbReference type="DOI" id="10.1016/S0092-8674(00)81701-8"/>
</citation>
<scope>INTERACTION WITH ZFYVE9</scope>
</reference>
<reference key="13">
<citation type="journal article" date="1998" name="J. Cell Biol." volume="140" first="767" last="777">
<title>Oligomeric structure of type I and type II transforming growth factor beta receptors: homodimers form in the ER and persist at the plasma membrane.</title>
<authorList>
<person name="Gilboa L."/>
<person name="Wells R.G."/>
<person name="Lodish H.F."/>
<person name="Henis Y.I."/>
</authorList>
<dbReference type="PubMed" id="9472030"/>
<dbReference type="DOI" id="10.1083/jcb.140.4.767"/>
</citation>
<scope>HOMODIMERIZATION</scope>
</reference>
<reference key="14">
<citation type="journal article" date="2001" name="Nat. Cell Biol." volume="3" first="708" last="714">
<title>TGF-beta-induced apoptosis is mediated by the adapter protein Daxx that facilitates JNK activation.</title>
<authorList>
<person name="Perlman R."/>
<person name="Schiemann W.P."/>
<person name="Brooks M.W."/>
<person name="Lodish H.F."/>
<person name="Weinberg R.A."/>
</authorList>
<dbReference type="PubMed" id="11483955"/>
<dbReference type="DOI" id="10.1038/35087019"/>
</citation>
<scope>INTERACTION WITH DAXX</scope>
<scope>MUTAGENESIS OF LYS-277</scope>
</reference>
<reference key="15">
<citation type="journal article" date="2003" name="EMBO J." volume="22" first="4465" last="4477">
<title>TLP, a novel modulator of TGF-beta signaling, has opposite effects on Smad2- and Smad3-dependent signaling.</title>
<authorList>
<person name="Felici A."/>
<person name="Wurthner J.U."/>
<person name="Parks W.T."/>
<person name="Giam L.R."/>
<person name="Reiss M."/>
<person name="Karpova T.S."/>
<person name="McNally J.G."/>
<person name="Roberts A.B."/>
</authorList>
<dbReference type="PubMed" id="12941698"/>
<dbReference type="DOI" id="10.1093/emboj/cdg428"/>
</citation>
<scope>INTERACTION WITH VPS39</scope>
</reference>
<reference key="16">
<citation type="journal article" date="2006" name="J. Biol. Chem." volume="281" first="37069" last="37080">
<title>Identification of Tctex2beta, a novel dynein light chain family member that interacts with different transforming growth factor-beta receptors.</title>
<authorList>
<person name="Meng Q.-J."/>
<person name="Lux A."/>
<person name="Holloschi A."/>
<person name="Li J."/>
<person name="Hughes J.M.X."/>
<person name="Foerg T."/>
<person name="McCarthy J.E.G."/>
<person name="Heagerty A.M."/>
<person name="Kioschis P."/>
<person name="Hafner M."/>
<person name="Garland J.M."/>
</authorList>
<dbReference type="PubMed" id="16982625"/>
<dbReference type="DOI" id="10.1074/jbc.M608614200"/>
</citation>
<scope>INTERACTION WITH TCTEX1D4</scope>
</reference>
<reference key="17">
<citation type="journal article" date="2008" name="Mol. Cell" volume="31" first="438" last="448">
<title>Kinase-selective enrichment enables quantitative phosphoproteomics of the kinome across the cell cycle.</title>
<authorList>
<person name="Daub H."/>
<person name="Olsen J.V."/>
<person name="Bairlein M."/>
<person name="Gnad F."/>
<person name="Oppermann F.S."/>
<person name="Korner R."/>
<person name="Greff Z."/>
<person name="Keri G."/>
<person name="Stemmann O."/>
<person name="Mann M."/>
</authorList>
<dbReference type="PubMed" id="18691976"/>
<dbReference type="DOI" id="10.1016/j.molcel.2008.07.007"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-548</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="18">
<citation type="journal article" date="2009" name="Mol. Cell. Proteomics" volume="8" first="1751" last="1764">
<title>Large-scale proteomics analysis of the human kinome.</title>
<authorList>
<person name="Oppermann F.S."/>
<person name="Gnad F."/>
<person name="Olsen J.V."/>
<person name="Hornberger R."/>
<person name="Greff Z."/>
<person name="Keri G."/>
<person name="Mann M."/>
<person name="Daub H."/>
</authorList>
<dbReference type="PubMed" id="19369195"/>
<dbReference type="DOI" id="10.1074/mcp.M800588-MCP200"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="19">
<citation type="journal article" date="2011" name="Oncogene" volume="30" first="3682" last="3693">
<title>SCUBE3 is an endogenous TGF-beta receptor ligand and regulates the epithelial-mesenchymal transition in lung cancer.</title>
<authorList>
<person name="Wu Y.Y."/>
<person name="Peck K."/>
<person name="Chang Y.L."/>
<person name="Pan S.H."/>
<person name="Cheng Y.F."/>
<person name="Lin J.C."/>
<person name="Yang R.B."/>
<person name="Hong T.M."/>
<person name="Yang P.C."/>
</authorList>
<dbReference type="PubMed" id="21441952"/>
<dbReference type="DOI" id="10.1038/onc.2011.85"/>
</citation>
<scope>INTERACTION WITH SCUBE3</scope>
</reference>
<reference key="20">
<citation type="journal article" date="2013" name="J. Proteome Res." volume="12" first="260" last="271">
<title>Toward a comprehensive characterization of a human cancer cell phosphoproteome.</title>
<authorList>
<person name="Zhou H."/>
<person name="Di Palma S."/>
<person name="Preisinger C."/>
<person name="Peng M."/>
<person name="Polat A.N."/>
<person name="Heck A.J."/>
<person name="Mohammed S."/>
</authorList>
<dbReference type="PubMed" id="23186163"/>
<dbReference type="DOI" id="10.1021/pr300630k"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-548</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="21">
<citation type="journal article" date="2014" name="J. Proteomics" volume="96" first="253" last="262">
<title>An enzyme assisted RP-RPLC approach for in-depth analysis of human liver phosphoproteome.</title>
<authorList>
<person name="Bian Y."/>
<person name="Song C."/>
<person name="Cheng K."/>
<person name="Dong M."/>
<person name="Wang F."/>
<person name="Huang J."/>
<person name="Sun D."/>
<person name="Wang L."/>
<person name="Ye M."/>
<person name="Zou H."/>
</authorList>
<dbReference type="PubMed" id="24275569"/>
<dbReference type="DOI" id="10.1016/j.jprot.2013.11.014"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-548</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Liver</tissue>
</source>
</reference>
<reference key="22">
<citation type="journal article" date="2016" name="Oncogene" volume="35" first="389" last="401">
<title>Syntenin regulates TGF-beta1-induced Smad activation and the epithelial-to-mesenchymal transition by inhibiting caveolin-mediated TGF-beta type I receptor internalization.</title>
<authorList>
<person name="Hwangbo C."/>
<person name="Tae N."/>
<person name="Lee S."/>
<person name="Kim O."/>
<person name="Park O.K."/>
<person name="Kim J."/>
<person name="Kwon S.H."/>
<person name="Lee J.H."/>
</authorList>
<dbReference type="PubMed" id="25893292"/>
<dbReference type="DOI" id="10.1038/onc.2015.100"/>
</citation>
<scope>SUBCELLULAR LOCATION</scope>
</reference>
<reference key="23">
<citation type="journal article" date="2002" name="Nat. Struct. Biol." volume="9" first="203" last="208">
<title>Crystal structure of the human TbetaR2 ectodomain--TGF-beta3 complex.</title>
<authorList>
<person name="Hart P.J."/>
<person name="Deep S."/>
<person name="Taylor A.B."/>
<person name="Shu Z."/>
<person name="Hinck C.S."/>
<person name="Hinck A.P."/>
</authorList>
<dbReference type="PubMed" id="11850637"/>
<dbReference type="DOI" id="10.1038/nsb766"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.15 ANGSTROMS) OF 38-159 IN COMPLEX WITH TGF-BETA3</scope>
<scope>DISULFIDE BONDS</scope>
</reference>
<reference key="24">
<citation type="journal article" date="2002" name="Structure" volume="10" first="913" last="919">
<title>The 1.1 A crystal structure of human TGF-beta type II receptor ligand binding domain.</title>
<authorList>
<person name="Boesen C.C."/>
<person name="Radaev S."/>
<person name="Motyka S.A."/>
<person name="Patamawenu A."/>
<person name="Sun P.D."/>
</authorList>
<dbReference type="PubMed" id="12121646"/>
<dbReference type="DOI" id="10.1016/S0969-2126(02)00780-3"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (1.05 ANGSTROMS) OF 49-159</scope>
<scope>DISULFIDE BONDS</scope>
</reference>
<reference key="25">
<citation type="journal article" date="2003" name="Biochemistry" volume="42" first="10126" last="10139">
<title>Solution structure and backbone dynamics of the TGFbeta type II receptor extracellular domain.</title>
<authorList>
<person name="Deep S."/>
<person name="Walker K.P. III"/>
<person name="Shu Z."/>
<person name="Hinck A.P."/>
</authorList>
<dbReference type="PubMed" id="12939140"/>
<dbReference type="DOI" id="10.1021/bi034366a"/>
</citation>
<scope>STRUCTURE BY NMR OF 38-159</scope>
<scope>DISULFIDE BONDS</scope>
</reference>
<reference key="26">
<citation type="journal article" date="2008" name="Mol. Cell" volume="29" first="157" last="168">
<title>Cooperative assembly of TGF-beta superfamily signaling complexes is mediated by two disparate mechanisms and distinct modes of receptor binding.</title>
<authorList>
<person name="Groppe J."/>
<person name="Hinck C.S."/>
<person name="Samavarchi-Tehrani P."/>
<person name="Zubieta C."/>
<person name="Schuermann J.P."/>
<person name="Taylor A.B."/>
<person name="Schwarz P.M."/>
<person name="Wrana J.L."/>
<person name="Hinck A.P."/>
</authorList>
<dbReference type="PubMed" id="18243111"/>
<dbReference type="DOI" id="10.1016/j.molcel.2007.11.039"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (3.00 ANGSTROMS) OF 43-149 IN COMPLEX WITH TGFBR1 AND TGFB3</scope>
<scope>DISULFIDE BONDS</scope>
</reference>
<reference key="27">
<citation type="journal article" date="2010" name="J. Biol. Chem." volume="285" first="14806" last="14814">
<title>Ternary complex of transforming growth factor-beta1 reveals isoform-specific ligand recognition and receptor recruitment in the superfamily.</title>
<authorList>
<person name="Radaev S."/>
<person name="Zou Z."/>
<person name="Huang T."/>
<person name="Lafer E.M."/>
<person name="Hinck A.P."/>
<person name="Sun P.D."/>
</authorList>
<dbReference type="PubMed" id="20207738"/>
<dbReference type="DOI" id="10.1074/jbc.M109.079921"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (3.00 ANGSTROMS) OF 38-153 IN COMPLEX WITH TGFBR1 AND TGFB1</scope>
<scope>RECEPTOR AFFINITY FOR LIGANDS</scope>
<scope>DISULFIDE BONDS</scope>
</reference>
<reference key="28">
<citation type="journal article" date="1998" name="Nat. Genet." volume="19" first="17" last="18">
<title>HNPCC associated with germline mutation in the TGF-beta type II receptor gene.</title>
<authorList>
<person name="Lu S.-L."/>
<person name="Kawabata M."/>
<person name="Imamura T."/>
<person name="Akiyama Y."/>
<person name="Nomizu T."/>
<person name="Miyazono K."/>
<person name="Yuasa Y."/>
</authorList>
<dbReference type="PubMed" id="9590282"/>
<dbReference type="DOI" id="10.1038/ng0598-17"/>
</citation>
<scope>VARIANT HNPCC6 MET-315</scope>
</reference>
<reference key="29">
<citation type="journal article" date="2000" name="Br. J. Cancer" volume="82" first="1557" last="1560">
<title>A dominant negative mutation of transforming growth factor-beta receptor type II gene in microsatellite stable oesophageal carcinoma.</title>
<authorList>
<person name="Tanaka S."/>
<person name="Mori M."/>
<person name="Mafune K."/>
<person name="Ohno S."/>
<person name="Sugimachi K."/>
</authorList>
<dbReference type="PubMed" id="10789724"/>
<dbReference type="DOI" id="10.1054/bjoc.1999.1178"/>
</citation>
<scope>VARIANT ESOPHAGEAL CANCER GLN-526</scope>
</reference>
<reference key="30">
<citation type="journal article" date="2001" name="Cancer Res." volume="61" first="482" last="485">
<title>Inhibiting mutations in the transforming growth factor beta type 2 receptor in recurrent human breast cancer.</title>
<authorList>
<person name="Luecke C.D."/>
<person name="Philpott A."/>
<person name="Metcalfe J.C."/>
<person name="Thompson A.M."/>
<person name="Hughes-Davies L."/>
<person name="Kemp P.R."/>
<person name="Hesketh R."/>
</authorList>
<dbReference type="PubMed" id="11212236"/>
</citation>
<scope>VARIANTS BREAST TUMOR MET-387; SER-435; ALA-447 AND MET-452</scope>
<scope>CHARACTERIZATION OF VARIANTS BREAST TUMOR SER-435; ALA-447 AND MET-452</scope>
</reference>
<reference key="31">
<citation type="journal article" date="2002" name="J. Hum. Genet." volume="47" first="478" last="483">
<title>A catalog of 106 single-nucleotide polymorphisms (SNPs) and 11 other types of variations in genes for transforming growth factor-beta1 (TGF-beta1) and its signaling pathway.</title>
<authorList>
<person name="Watanabe Y."/>
<person name="Kinoshita A."/>
<person name="Yamada T."/>
<person name="Ohta T."/>
<person name="Kishino T."/>
<person name="Matsumoto N."/>
<person name="Ishikawa M."/>
<person name="Niikawa N."/>
<person name="Yoshiura K."/>
</authorList>
<dbReference type="PubMed" id="12202987"/>
<dbReference type="DOI" id="10.1007/s100380200069"/>
</citation>
<scope>VARIANT ILE-191</scope>
</reference>
<reference key="32">
<citation type="journal article" date="2004" name="Nat. Genet." volume="36" first="855" last="860">
<title>Heterozygous TGFBR2 mutations in Marfan syndrome.</title>
<authorList>
<person name="Mizuguchi T."/>
<person name="Collod-Beroud G."/>
<person name="Akiyama T."/>
<person name="Abifadel M."/>
<person name="Harada N."/>
<person name="Morisaki T."/>
<person name="Allard D."/>
<person name="Varret M."/>
<person name="Claustres M."/>
<person name="Morisaki H."/>
<person name="Ihara M."/>
<person name="Kinoshita A."/>
<person name="Yoshiura K."/>
<person name="Junien C."/>
<person name="Kajii T."/>
<person name="Jondeau G."/>
<person name="Ohta T."/>
<person name="Kishino T."/>
<person name="Furukawa Y."/>
<person name="Nakamura Y."/>
<person name="Niikawa N."/>
<person name="Boileau C."/>
<person name="Matsumoto N."/>
</authorList>
<dbReference type="PubMed" id="15235604"/>
<dbReference type="DOI" id="10.1038/ng1392"/>
</citation>
<scope>VARIANTS LDS2 PRO-308; PHE-449 AND CYS-537</scope>
<scope>CHARACTERIZATION OF VARIANTS LDS2 PRO-308; PHE-449 AND CYS-537</scope>
</reference>
<reference key="33">
<citation type="journal article" date="2005" name="Circulation" volume="112" first="513" last="520">
<title>Mutations in transforming growth factor-beta receptor type II cause familial thoracic aortic aneurysms and dissections.</title>
<authorList>
<person name="Pannu H."/>
<person name="Fadulu V.T."/>
<person name="Chang J."/>
<person name="Lafont A."/>
<person name="Hasham S.N."/>
<person name="Sparks E."/>
<person name="Giampietro P.F."/>
<person name="Zaleski C."/>
<person name="Estrera A.L."/>
<person name="Safi H.J."/>
<person name="Shete S."/>
<person name="Willing M.C."/>
<person name="Raman C.S."/>
<person name="Milewicz D.M."/>
</authorList>
<dbReference type="PubMed" id="16027248"/>
<dbReference type="DOI" id="10.1161/CIRCULATIONAHA.105.537340"/>
</citation>
<scope>VARIANTS LDS2 CYS-460 AND HIS-460</scope>
</reference>
<reference key="34">
<citation type="journal article" date="2005" name="Nat. Genet." volume="37" first="275" last="281">
<title>A syndrome of altered cardiovascular, craniofacial, neurocognitive and skeletal development caused by mutations in TGFBR1 or TGFBR2.</title>
<authorList>
<person name="Loeys B.L."/>
<person name="Chen J."/>
<person name="Neptune E.R."/>
<person name="Judge D.P."/>
<person name="Podowski M."/>
<person name="Holm T."/>
<person name="Meyers J."/>
<person name="Leitch C.C."/>
<person name="Katsanis N."/>
<person name="Sharifi N."/>
<person name="Xu F.L."/>
<person name="Myers L.A."/>
<person name="Spevak P.J."/>
<person name="Cameron D.E."/>
<person name="De Backer J.F."/>
<person name="Hellemans J."/>
<person name="Chen Y."/>
<person name="Davis E.C."/>
<person name="Webb C.L."/>
<person name="Kress W."/>
<person name="Coucke P.J."/>
<person name="Rifkin D.B."/>
<person name="De Paepe A.M."/>
<person name="Dietz H.C."/>
</authorList>
<dbReference type="PubMed" id="15731757"/>
<dbReference type="DOI" id="10.1038/ng1511"/>
</citation>
<scope>VARIANTS LDS2 ASN-336; PRO-355; TRP-357; HIS-528 AND CYS-528</scope>
</reference>
<reference key="35">
<citation type="journal article" date="2006" name="Eur. J. Hum. Genet." volume="14" first="34" last="38">
<title>Two novel and one known mutation of the TGFBR2 gene in Marfan syndrome not associated with FBN1 gene defects.</title>
<authorList>
<person name="Disabella E."/>
<person name="Grasso M."/>
<person name="Marziliano N."/>
<person name="Ansaldi S."/>
<person name="Lucchelli C."/>
<person name="Porcu E."/>
<person name="Tagliani M."/>
<person name="Pilotto A."/>
<person name="Diegoli M."/>
<person name="Lanzarini L."/>
<person name="Malattia C."/>
<person name="Pelliccia A."/>
<person name="Ficcadenti A."/>
<person name="Gabrielli O."/>
<person name="Arbustini E."/>
</authorList>
<dbReference type="PubMed" id="16251899"/>
<dbReference type="DOI" id="10.1038/sj.ejhg.5201502"/>
</citation>
<scope>VARIANT LDS2 ASN-446</scope>
</reference>
<reference key="36">
<citation type="journal article" date="2006" name="Science" volume="314" first="268" last="274">
<title>The consensus coding sequences of human breast and colorectal cancers.</title>
<authorList>
<person name="Sjoeblom T."/>
<person name="Jones S."/>
<person name="Wood L.D."/>
<person name="Parsons D.W."/>
<person name="Lin J."/>
<person name="Barber T.D."/>
<person name="Mandelker D."/>
<person name="Leary R.J."/>
<person name="Ptak J."/>
<person name="Silliman N."/>
<person name="Szabo S."/>
<person name="Buckhaults P."/>
<person name="Farrell C."/>
<person name="Meeh P."/>
<person name="Markowitz S.D."/>
<person name="Willis J."/>
<person name="Dawson D."/>
<person name="Willson J.K.V."/>
<person name="Gazdar A.F."/>
<person name="Hartigan J."/>
<person name="Wu L."/>
<person name="Liu C."/>
<person name="Parmigiani G."/>
<person name="Park B.H."/>
<person name="Bachman K.E."/>
<person name="Papadopoulos N."/>
<person name="Vogelstein B."/>
<person name="Kinzler K.W."/>
<person name="Velculescu V.E."/>
</authorList>
<dbReference type="PubMed" id="16959974"/>
<dbReference type="DOI" id="10.1126/science.1133427"/>
</citation>
<scope>VARIANTS [LARGE SCALE ANALYSIS] VAL-73 AND HIS-528</scope>
</reference>
<reference key="37">
<citation type="journal article" date="2007" name="Nature" volume="446" first="153" last="158">
<title>Patterns of somatic mutation in human cancer genomes.</title>
<authorList>
<person name="Greenman C."/>
<person name="Stephens P."/>
<person name="Smith R."/>
<person name="Dalgliesh G.L."/>
<person name="Hunter C."/>
<person name="Bignell G."/>
<person name="Davies H."/>
<person name="Teague J."/>
<person name="Butler A."/>
<person name="Stevens C."/>
<person name="Edkins S."/>
<person name="O'Meara S."/>
<person name="Vastrik I."/>
<person name="Schmidt E.E."/>
<person name="Avis T."/>
<person name="Barthorpe S."/>
<person name="Bhamra G."/>
<person name="Buck G."/>
<person name="Choudhury B."/>
<person name="Clements J."/>
<person name="Cole J."/>
<person name="Dicks E."/>
<person name="Forbes S."/>
<person name="Gray K."/>
<person name="Halliday K."/>
<person name="Harrison R."/>
<person name="Hills K."/>
<person name="Hinton J."/>
<person name="Jenkinson A."/>
<person name="Jones D."/>
<person name="Menzies A."/>
<person name="Mironenko T."/>
<person name="Perry J."/>
<person name="Raine K."/>
<person name="Richardson D."/>
<person name="Shepherd R."/>
<person name="Small A."/>
<person name="Tofts C."/>
<person name="Varian J."/>
<person name="Webb T."/>
<person name="West S."/>
<person name="Widaa S."/>
<person name="Yates A."/>
<person name="Cahill D.P."/>
<person name="Louis D.N."/>
<person name="Goldstraw P."/>
<person name="Nicholson A.G."/>
<person name="Brasseur F."/>
<person name="Looijenga L."/>
<person name="Weber B.L."/>
<person name="Chiew Y.-E."/>
<person name="DeFazio A."/>
<person name="Greaves M.F."/>
<person name="Green A.R."/>
<person name="Campbell P."/>
<person name="Birney E."/>
<person name="Easton D.F."/>
<person name="Chenevix-Trench G."/>
<person name="Tan M.-H."/>
<person name="Khoo S.K."/>
<person name="Teh B.T."/>
<person name="Yuen S.T."/>
<person name="Leung S.Y."/>
<person name="Wooster R."/>
<person name="Futreal P.A."/>
<person name="Stratton M.R."/>
</authorList>
<dbReference type="PubMed" id="17344846"/>
<dbReference type="DOI" id="10.1038/nature05610"/>
</citation>
<scope>VARIANTS [LARGE SCALE ANALYSIS] ARG-61; ILE-191; MET-315; TYR-328; ILE-373; MET-387 AND SER-490</scope>
</reference>
<reference key="38">
<citation type="journal article" date="2009" name="Am. J. Med. Genet. A" volume="149A" first="1452" last="1459">
<title>Identification of novel FBN1 and TGFBR2 mutations in 65 probands with Marfan syndrome or Marfan-like phenotypes.</title>
<authorList>
<person name="Chung B.H."/>
<person name="Lam S.T."/>
<person name="Tong T.M."/>
<person name="Li S.Y."/>
<person name="Lun K.S."/>
<person name="Chan D.H."/>
<person name="Fok S.F."/>
<person name="Or J.S."/>
<person name="Smith D.K."/>
<person name="Yang W."/>
<person name="Lau Y.L."/>
</authorList>
<dbReference type="PubMed" id="19533785"/>
<dbReference type="DOI" id="10.1002/ajmg.a.32918"/>
</citation>
<scope>VARIANTS LDS2 HIS-190; VAL-247; PRO-325; ARG-357 AND ILE-530</scope>
</reference>
<reference key="39">
<citation type="journal article" date="2009" name="Orphanet J. Rare Dis." volume="4" first="24" last="24">
<title>Loeys-Dietz syndrome type I and type II: clinical findings and novel mutations in two Italian patients.</title>
<authorList>
<person name="Drera B."/>
<person name="Ritelli M."/>
<person name="Zoppi N."/>
<person name="Wischmeijer A."/>
<person name="Gnoli M."/>
<person name="Fattori R."/>
<person name="Calzavara-Pinton P.G."/>
<person name="Barlati S."/>
<person name="Colombi M."/>
</authorList>
<dbReference type="PubMed" id="19883511"/>
<dbReference type="DOI" id="10.1186/1750-1172-4-24"/>
</citation>
<scope>VARIANT LDS2 SER-510</scope>
</reference>
<reference key="40">
<citation type="journal article" date="2010" name="Am. J. Med. Genet. A" volume="152" first="417" last="421">
<title>Progressive aortic root and pulmonary artery aneurysms in a neonate with Loeys-Dietz syndrome type 1B.</title>
<authorList>
<person name="Muramatsu Y."/>
<person name="Kosho T."/>
<person name="Magota M."/>
<person name="Yokotsuka T."/>
<person name="Ito M."/>
<person name="Yasuda A."/>
<person name="Kito O."/>
<person name="Suzuki C."/>
<person name="Nagata Y."/>
<person name="Kawai S."/>
<person name="Ikoma M."/>
<person name="Hatano T."/>
<person name="Nakayama M."/>
<person name="Kawamura R."/>
<person name="Wakui K."/>
<person name="Morisaki H."/>
<person name="Morisaki T."/>
<person name="Fukushima Y."/>
</authorList>
<dbReference type="PubMed" id="20101701"/>
<dbReference type="DOI" id="10.1002/ajmg.a.33263"/>
</citation>
<scope>VARIANT LDS2 LYS-457</scope>
</reference>
<reference key="41">
<citation type="journal article" date="2010" name="Am. J. Med. Genet. A" volume="152" first="1016" last="1019">
<title>Germline TGF-beta receptor mutations and skeletal fragility: a report on two patients with Loeys-Dietz syndrome.</title>
<authorList>
<person name="Kirmani S."/>
<person name="Tebben P.J."/>
<person name="Lteif A.N."/>
<person name="Gordon D."/>
<person name="Clarke B.L."/>
<person name="Hefferan T.E."/>
<person name="Yaszemski M.J."/>
<person name="McGrann P.S."/>
<person name="Lindor N.M."/>
<person name="Ellison J.W."/>
</authorList>
<dbReference type="PubMed" id="20358619"/>
<dbReference type="DOI" id="10.1002/ajmg.a.33356"/>
</citation>
<scope>VARIANTS LDS2 PRO-308 AND ARG-521</scope>
</reference>
<reference key="42">
<citation type="journal article" date="2012" name="J. Hum. Genet." volume="57" first="52" last="56">
<title>Clinical features and genetic analysis of Korean patients with Loeys-Dietz syndrome.</title>
<authorList>
<person name="Yang J.H."/>
<person name="Ki C.S."/>
<person name="Han H."/>
<person name="Song B.G."/>
<person name="Jang S.Y."/>
<person name="Chung T.Y."/>
<person name="Sung K."/>
<person name="Lee H.J."/>
<person name="Kim D.K."/>
</authorList>
<dbReference type="PubMed" id="22113417"/>
<dbReference type="DOI" id="10.1038/jhg.2011.130"/>
</citation>
<scope>VARIANTS LDS2 GLN-306 DELINS HIS-GLU; ARG-377; PHE-449 AND ARG-514</scope>
</reference>
<reference key="43">
<citation type="journal article" date="2011" name="Korean J. Pediatr." volume="54" first="272" last="275">
<title>A sporadic case of Loeys-Dietz syndrome type I with two novel mutations of the TGFBR2 gene.</title>
<authorList>
<person name="Ha J.S."/>
<person name="Kim Y.H."/>
</authorList>
<dbReference type="PubMed" id="21949523"/>
<dbReference type="DOI" id="10.3345/kjp.2011.54.6.272"/>
</citation>
<scope>VARIANTS LDS2 VAL-509 AND PHE-510</scope>
</reference>
<comment type="function">
<text evidence="40">Transmembrane serine/threonine kinase forming with the TGF-beta type I serine/threonine kinase receptor, TGFBR1, the non-promiscuous receptor for the TGF-beta cytokines TGFB1, TGFB2 and TGFB3. Transduces the TGFB1, TGFB2 and TGFB3 signal from the cell surface to the cytoplasm and is thus regulating a plethora of physiological and pathological processes including cell cycle arrest in epithelial and hematopoietic cells, control of mesenchymal cell proliferation and differentiation, wound healing, extracellular matrix production, immunosuppression and carcinogenesis. The formation of the receptor complex composed of 2 TGFBR1 and 2 TGFBR2 molecules symmetrically bound to the cytokine dimer results in the phosphorylation and the activation of TGFRB1 by the constitutively active TGFBR2. Activated TGFBR1 phosphorylates SMAD2 which dissociates from the receptor and interacts with SMAD4. The SMAD2-SMAD4 complex is subsequently translocated to the nucleus where it modulates the transcription of the TGF-beta-regulated genes. This constitutes the canonical SMAD-dependent TGF-beta signaling cascade. Also involved in non-canonical, SMAD-independent TGF-beta signaling pathways.</text>
</comment>
<comment type="catalytic activity">
<text>ATP + [receptor-protein] = ADP + [receptor-protein] phosphate.</text>
</comment>
<comment type="cofactor">
<cofactor evidence="8">
<name>Mg(2+)</name>
<dbReference type="ChEBI" id="CHEBI:18420"/>
</cofactor>
<cofactor evidence="8">
<name>Mn(2+)</name>
<dbReference type="ChEBI" id="CHEBI:29035"/>
</cofactor>
</comment>
<comment type="subunit">
<text evidence="15 16 20 28 30 34 36 45">Homodimer. Heterohexamer; TGFB1, TGFB2 and TGFB3 homodimeric ligands assemble a functional receptor composed of two TGFBR1 and TGFBR2 heterodimers to form a ligand-receptor heterohexamer. The respective affinity of TGFRB1 and TGFRB2 for the ligands may modulate the kinetics of assembly of the receptor and may explain the different biological activities of TGFB1, TGFB2 and TGFB3. Interacts with DAXX. Interacts with TCTEX1D4. Interacts with ZFYVE9; ZFYVE9 recruits SMAD2 and SMAD3 to the TGF-beta receptor. Interacts with and is activated by SCUBE3; this interaction does not affect TGFB1-binding to TGFBR2. Interacts with VPS39; this interaction is independent of the receptor kinase activity and of the presence of TGF-beta.</text>
</comment>
<comment type="interaction">
<interactant intactId="EBI-296151"/>
<interactant intactId="EBI-77321">
<id>Q9UER7</id>
<label>DAXX</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-296151"/>
<interactant intactId="EBI-394357">
<id>Q93074</id>
<label>MED12</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-296151"/>
<interactant intactId="EBI-5744969">
<id>A2AGH6</id>
<label>Med12</label>
</interactant>
<organismsDiffer>true</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-296151"/>
<interactant intactId="EBI-4479975">
<id>Q8IX30</id>
<label>SCUBE3</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>6</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-296151"/>
<interactant intactId="EBI-779636">
<id>P01137</id>
<label>TGFB1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>6</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-296151"/>
<interactant intactId="EBI-907660">
<id>P07200</id>
<label>TGFB1</label>
</interactant>
<organismsDiffer>true</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-296151"/>
<interactant intactId="EBI-1033020">
<id>P10600</id>
<label>TGFB3</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>8</experiments>
</comment>
<comment type="subcellular location">
<subcellularLocation>
<location evidence="21 39">Cell membrane</location>
<topology evidence="21">Single-pass type I membrane protein</topology>
</subcellularLocation>
<subcellularLocation>
<location evidence="39">Membrane raft</location>
</subcellularLocation>
</comment>
<comment type="alternative products">
<event type="alternative splicing"/>
<isoform>
<id>P37173-1</id>
<name>1</name>
<sequence type="displayed"/>
</isoform>
<isoform>
<id>P37173-2</id>
<name>2</name>
<sequence type="described" ref="VSP_012157"/>
</isoform>
</comment>
<comment type="PTM">
<text>Phosphorylated on a Ser/Thr residue in the cytoplasmic domain.</text>
</comment>
<comment type="disease" evidence="44">
<disease id="DI-00555">
<name>Hereditary non-polyposis colorectal cancer 6</name>
<acronym>HNPCC6</acronym>
<description>An autosomal dominant disease associated with marked increase in cancer susceptibility. It is characterized by a familial predisposition to early-onset colorectal carcinoma (CRC) and extra-colonic tumors of the gastrointestinal, urological and female reproductive tracts. HNPCC is reported to be the most common form of inherited colorectal cancer in the Western world. Clinically, HNPCC is often divided into two subgroups. Type I is characterized by hereditary predisposition to colorectal cancer, a young age of onset, and carcinoma observed in the proximal colon. Type II is characterized by increased risk for cancers in certain tissues such as the uterus, ovary, breast, stomach, small intestine, skin, and larynx in addition to the colon. Diagnosis of classical HNPCC is based on the Amsterdam criteria: 3 or more relatives affected by colorectal cancer, one a first degree relative of the other two; 2 or more generation affected; 1 or more colorectal cancers presenting before 50 years of age; exclusion of hereditary polyposis syndromes. The term 'suspected HNPCC' or 'incomplete HNPCC' can be used to describe families who do not or only partially fulfill the Amsterdam criteria, but in whom a genetic basis for colon cancer is strongly suspected.</description>
<dbReference type="MIM" id="614331"/>
</disease>
<text>The disease is caused by mutations affecting the gene represented in this entry.</text>
</comment>
<comment type="disease" evidence="13">
<disease id="DI-01537">
<name>Esophageal cancer</name>
<acronym>ESCR</acronym>
<description>A malignancy of the esophagus. The most common types are esophageal squamous cell carcinoma and adenocarcinoma. Cancer of the esophagus remains a devastating disease because it is usually not detected until it has progressed to an advanced incurable stage.</description>
<dbReference type="MIM" id="133239"/>
</disease>
<text>The disease is caused by mutations affecting the gene represented in this entry.</text>
</comment>
<comment type="disease" evidence="22 24 25 26 31 32 33 35 37 38">
<disease id="DI-00677">
<name>Loeys-Dietz syndrome 2</name>
<acronym>LDS2</acronym>
<description>An aortic aneurysm syndrome with widespread systemic involvement, characterized by arterial tortuosity and aneurysms, hypertelorism, and bifid uvula or cleft palate. Physical findings include prominent joint laxity, easy bruising, wide and atrophic scars, velvety and translucent skin with easily visible veins, spontaneous rupture of the spleen or bowel, and catastrophic complications of pregnancy, including rupture of the gravid uterus and the arteries, either during pregnancy or in the immediate postpartum period. Some patients have craniosynostosis, exotropy, micrognathia and retrognathia, structural brain abnormalities, and intellectual deficit.</description>
<dbReference type="MIM" id="610168"/>
</disease>
<text evidence="25">The disease is caused by mutations affecting the gene represented in this entry. TGFBR2 mutations Cys-460 and His-460 have been reported to be associated with thoracic aortic aneurysms and dissection (TAAD). This phenotype, also known as thoracic aortic aneurysms type 3 (AAT3), is distinguised from LDS2 by having aneurysms restricted to thoracic aorta. As individuals carrying these mutations also exhibit descending aortic disease and aneurysms of other arteries (PubMed:16027248), they have been considered as LDS2 by the OMIM resource.</text>
</comment>
<comment type="similarity">
<text evidence="49">Belongs to the protein kinase superfamily. TKL Ser/Thr protein kinase family. TGFB receptor subfamily.</text>
</comment>
<comment type="online information" name="NIEHS-SNPs">
<link uri="http://egp.gs.washington.edu/data/tgfbr2/"/>
</comment>
<dbReference type="EC" id="2.7.11.30"/>
<dbReference type="EMBL" id="M85079">
<property type="protein sequence ID" value="AAA61164.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="D28131">
<property type="protein sequence ID" value="BAA05673.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="U52246">
<property type="protein sequence ID" value="AAB17553.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="U52240">
<property type="protein sequence ID" value="AAB17553.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="U52241">
<property type="protein sequence ID" value="AAB17553.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="U52242">
<property type="protein sequence ID" value="AAB17553.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="U52244">
<property type="protein sequence ID" value="AAB17553.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="U52245">
<property type="protein sequence ID" value="AAB17553.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="U69152">
<property type="protein sequence ID" value="AAB40916.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="U69146">
<property type="protein sequence ID" value="AAB40916.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="U69147">
<property type="protein sequence ID" value="AAB40916.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="U69148">
<property type="protein sequence ID" value="AAB40916.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="U69149">
<property type="protein sequence ID" value="AAB40916.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="U69150">
<property type="protein sequence ID" value="AAB40916.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="U69151">
<property type="protein sequence ID" value="AAB40916.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="D50683">
<property type="protein sequence ID" value="BAA09332.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AY675319">
<property type="protein sequence ID" value="AAT70724.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AK300383">
<property type="protein sequence ID" value="BAG62117.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="CH471055">
<property type="protein sequence ID" value="EAW64412.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="CCDS" id="CCDS2648.1">
<molecule id="P37173-1"/>
</dbReference>
<dbReference type="CCDS" id="CCDS33727.1">
<molecule id="P37173-2"/>
</dbReference>
<dbReference type="PIR" id="A42100">
<property type="entry name" value="A42100"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001020018.1">
<molecule id="P37173-2"/>
<property type="nucleotide sequence ID" value="NM_001024847.2"/>
</dbReference>
<dbReference type="RefSeq" id="NP_003233.4">
<molecule id="P37173-1"/>
<property type="nucleotide sequence ID" value="NM_003242.5"/>
</dbReference>
<dbReference type="UniGene" id="Hs.604277"/>
<dbReference type="UniGene" id="Hs.82028"/>
<dbReference type="PDB" id="1KTZ">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.15"/>
<property type="chains" value="B=38-159"/>
</dbReference>
<dbReference type="PDB" id="1M9Z">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.05"/>
<property type="chains" value="A=49-159"/>
</dbReference>
<dbReference type="PDB" id="1PLO">
<property type="method" value="NMR"/>
<property type="chains" value="A=38-159"/>
</dbReference>
<dbReference type="PDB" id="2PJY">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.00"/>
<property type="chains" value="B=42-149"/>
</dbReference>
<dbReference type="PDB" id="3KFD">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.00"/>
<property type="chains" value="E/F/G/H=38-153"/>
</dbReference>
<dbReference type="PDB" id="4P7U">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.50"/>
<property type="chains" value="A=49-159"/>
</dbReference>
<dbReference type="PDB" id="4XJJ">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.40"/>
<property type="chains" value="A=50-159"/>
</dbReference>
<dbReference type="PDB" id="5E8V">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.69"/>
<property type="chains" value="A=237-549"/>
</dbReference>
<dbReference type="PDB" id="5E8Y">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.05"/>
<property type="chains" value="A=237-549"/>
</dbReference>
<dbReference type="PDB" id="5E91">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.42"/>
<property type="chains" value="A=237-549"/>
</dbReference>
<dbReference type="PDB" id="5E92">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.08"/>
<property type="chains" value="A=237-549"/>
</dbReference>
<dbReference type="PDB" id="5TX4">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.88"/>
<property type="chains" value="A=38-153"/>
</dbReference>
<dbReference type="PDBsum" id="1KTZ"/>
<dbReference type="PDBsum" id="1M9Z"/>
<dbReference type="PDBsum" id="1PLO"/>
<dbReference type="PDBsum" id="2PJY"/>
<dbReference type="PDBsum" id="3KFD"/>
<dbReference type="PDBsum" id="4P7U"/>
<dbReference type="PDBsum" id="4XJJ"/>
<dbReference type="PDBsum" id="5E8V"/>
<dbReference type="PDBsum" id="5E8Y"/>
<dbReference type="PDBsum" id="5E91"/>
<dbReference type="PDBsum" id="5E92"/>
<dbReference type="PDBsum" id="5TX4"/>
<dbReference type="ProteinModelPortal" id="P37173"/>
<dbReference type="SMR" id="P37173"/>
<dbReference type="BioGrid" id="112906">
<property type="interactions" value="86"/>
</dbReference>
<dbReference type="DIP" id="DIP-5939N"/>
<dbReference type="IntAct" id="P37173">
<property type="interactions" value="26"/>
</dbReference>
<dbReference type="MINT" id="MINT-206666"/>
<dbReference type="STRING" id="9606.ENSP00000351905"/>
<dbReference type="BindingDB" id="P37173"/>
<dbReference type="ChEMBL" id="CHEMBL4267"/>
<dbReference type="DrugBank" id="DB04077">
<property type="generic name" value="Glycerol"/>
</dbReference>
<dbReference type="GuidetoPHARMACOLOGY" id="1795"/>
<dbReference type="iPTMnet" id="P37173"/>
<dbReference type="PhosphoSitePlus" id="P37173"/>
<dbReference type="BioMuta" id="TGFBR2"/>
<dbReference type="DMDM" id="116242818"/>
<dbReference type="MaxQB" id="P37173"/>
<dbReference type="PaxDb" id="P37173"/>
<dbReference type="PeptideAtlas" id="P37173"/>
<dbReference type="PRIDE" id="P37173"/>
<dbReference type="DNASU" id="7048"/>
<dbReference type="Ensembl" id="ENST00000295754">
<molecule id="P37173-1"/>
<property type="protein sequence ID" value="ENSP00000295754"/>
<property type="gene ID" value="ENSG00000163513"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000359013">
<molecule id="P37173-2"/>
<property type="protein sequence ID" value="ENSP00000351905"/>
<property type="gene ID" value="ENSG00000163513"/>
</dbReference>
<dbReference type="GeneID" id="7048"/>
<dbReference type="KEGG" id="hsa:7048"/>
<dbReference type="UCSC" id="uc003cen.4">
<molecule id="P37173-1"/>
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="CTD" id="7048"/>
<dbReference type="DisGeNET" id="7048"/>
<dbReference type="GeneCards" id="TGFBR2"/>
<dbReference type="GeneReviews" id="TGFBR2"/>
<dbReference type="H-InvDB" id="HIX0024332"/>
<dbReference type="HGNC" id="HGNC:11773">
<property type="gene designation" value="TGFBR2"/>
</dbReference>
<dbReference type="HPA" id="CAB073537"/>
<dbReference type="MalaCards" id="TGFBR2"/>
<dbReference type="MIM" id="133239">
<property type="type" value="phenotype"/>
</dbReference>
<dbReference type="MIM" id="190182">
<property type="type" value="gene"/>
</dbReference>
<dbReference type="MIM" id="610168">
<property type="type" value="phenotype"/>
</dbReference>
<dbReference type="MIM" id="614331">
<property type="type" value="phenotype"/>
</dbReference>
<dbReference type="neXtProt" id="NX_P37173"/>
<dbReference type="OpenTargets" id="ENSG00000163513"/>
<dbReference type="Orphanet" id="91387">
<property type="disease" value="Familial thoracic aortic aneurysm and aortic dissection"/>
</dbReference>
<dbReference type="Orphanet" id="144">
<property type="disease" value="Hereditary nonpolyposis colon cancer"/>
</dbReference>
<dbReference type="Orphanet" id="60030">
<property type="disease" value="Loeys-Dietz syndrome"/>
</dbReference>
<dbReference type="Orphanet" id="284973">
<property type="disease" value="Marfan syndrome type 2"/>
</dbReference>
<dbReference type="PharmGKB" id="PA36486"/>
<dbReference type="eggNOG" id="KOG3653">
<property type="taxonomic scope" value="Eukaryota"/>
</dbReference>
<dbReference type="eggNOG" id="ENOG410XS2Z">
<property type="taxonomic scope" value="LUCA"/>
</dbReference>
<dbReference type="GeneTree" id="ENSGT00760000118876"/>
<dbReference type="HOGENOM" id="HOG000231495"/>
<dbReference type="HOVERGEN" id="HBG104975"/>
<dbReference type="InParanoid" id="P37173"/>
<dbReference type="KO" id="K04388"/>
<dbReference type="OMA" id="TRHIISW"/>
<dbReference type="PhylomeDB" id="P37173"/>
<dbReference type="TreeFam" id="TF314724"/>
<dbReference type="BRENDA" id="2.7.10.2">
<property type="organism ID" value="2681"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-2173788">
<property type="pathway name" value="Downregulation of TGF-beta receptor signaling"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-2173789">
<property type="pathway name" value="TGF-beta receptor signaling activates SMADs"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-2173791">
<property type="pathway name" value="TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition)"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-3304356">
<property type="pathway name" value="SMAD2/3 Phosphorylation Motif Mutants in Cancer"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-3315487">
<property type="pathway name" value="SMAD2/3 MH2 Domain Mutants in Cancer"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-3642279">
<property type="pathway name" value="TGFBR2 MSI Frameshift Mutants in Cancer"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-3645790">
<property type="pathway name" value="TGFBR2 Kinase Domain Mutants in Cancer"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-3656532">
<property type="pathway name" value="TGFBR1 KD Mutants in Cancer"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-3656535">
<property type="pathway name" value="TGFBR1 LBD Mutants in Cancer"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-5689603">
<property type="pathway name" value="UCH proteinases"/>
</dbReference>
<dbReference type="SignaLink" id="P37173"/>
<dbReference type="SIGNOR" id="P37173"/>
<dbReference type="ChiTaRS" id="TGFBR2">
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="EvolutionaryTrace" id="P37173"/>
<dbReference type="GeneWiki" id="TGF_beta_receptor_2"/>
<dbReference type="GenomeRNAi" id="7048"/>
<dbReference type="PRO" id="PR:P37173"/>
<dbReference type="Proteomes" id="UP000005640">
<property type="component" value="Chromosome 3"/>
</dbReference>
<dbReference type="Bgee" id="ENSG00000163513"/>
<dbReference type="CleanEx" id="HS_TGFBR2"/>
<dbReference type="ExpressionAtlas" id="P37173">
<property type="expression patterns" value="baseline and differential"/>
</dbReference>
<dbReference type="Genevisible" id="P37173">
<property type="organism ID" value="HS"/>
</dbReference>
<dbReference type="GO" id="GO:0005901">
<property type="term" value="C:caveola"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0005829">
<property type="term" value="C:cytosol"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0009897">
<property type="term" value="C:external side of plasma membrane"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0016021">
<property type="term" value="C:integral component of membrane"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0045121">
<property type="term" value="C:membrane raft"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005886">
<property type="term" value="C:plasma membrane"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0043235">
<property type="term" value="C:receptor complex"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0070022">
<property type="term" value="C:transforming growth factor beta receptor complex"/>
<property type="evidence" value="ECO:0000305"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0005524">
<property type="term" value="F:ATP binding"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0005539">
<property type="term" value="F:glycosaminoglycan binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0046872">
<property type="term" value="F:metal ion binding"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0031435">
<property type="term" value="F:mitogen-activated protein kinase kinase kinase binding"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0004702">
<property type="term" value="F:signal transducer, downstream of receptor, with serine/threonine kinase activity"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="InterPro"/>
</dbReference>
<dbReference type="GO" id="GO:0046332">
<property type="term" value="F:SMAD binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0050431">
<property type="term" value="F:transforming growth factor beta binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0005026">
<property type="term" value="F:transforming growth factor beta receptor activity, type II"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0005024">
<property type="term" value="F:transforming growth factor beta-activated receptor activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0004675">
<property type="term" value="F:transmembrane receptor protein serine/threonine kinase activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0034713">
<property type="term" value="F:type I transforming growth factor beta receptor binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0034714">
<property type="term" value="F:type III transforming growth factor beta receptor binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0032147">
<property type="term" value="P:activation of protein kinase activity"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0007568">
<property type="term" value="P:aging"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0031100">
<property type="term" value="P:animal organ regeneration"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0006915">
<property type="term" value="P:apoptotic process"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0003181">
<property type="term" value="P:atrioventricular valve morphogenesis"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0001568">
<property type="term" value="P:blood vessel development"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0007420">
<property type="term" value="P:brain development"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0001569">
<property type="term" value="P:branching involved in blood vessel morphogenesis"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0060434">
<property type="term" value="P:bronchus morphogenesis"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0003214">
<property type="term" value="P:cardiac left ventricle morphogenesis"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0007182">
<property type="term" value="P:common-partner SMAD protein phosphorylation"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0048565">
<property type="term" value="P:digestive tract development"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0007566">
<property type="term" value="P:embryo implantation"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0048701">
<property type="term" value="P:embryonic cranial skeleton morphogenesis"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0035162">
<property type="term" value="P:embryonic hemopoiesis"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0003274">
<property type="term" value="P:endocardial cushion fusion"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0007369">
<property type="term" value="P:gastrulation"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0003430">
<property type="term" value="P:growth plate cartilage chondrocyte growth"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0007507">
<property type="term" value="P:heart development"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0001947">
<property type="term" value="P:heart looping"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0001701">
<property type="term" value="P:in utero embryonic development"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0002088">
<property type="term" value="P:lens development in camera-type eye"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:1990086">
<property type="term" value="P:lens fiber cell apoptotic process"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0060463">
<property type="term" value="P:lung lobe morphogenesis"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0060443">
<property type="term" value="P:mammary gland morphogenesis"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0003149">
<property type="term" value="P:membranous septum morphogenesis"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0043011">
<property type="term" value="P:myeloid dendritic cell differentiation"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0060044">
<property type="term" value="P:negative regulation of cardiac muscle cell proliferation"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0030512">
<property type="term" value="P:negative regulation of transforming growth factor beta receptor signaling pathway"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0007219">
<property type="term" value="P:Notch signaling pathway"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0003151">
<property type="term" value="P:outflow tract morphogenesis"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0003148">
<property type="term" value="P:outflow tract septum morphogenesis"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0060021">
<property type="term" value="P:palate development"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0060389">
<property type="term" value="P:pathway-restricted SMAD protein phosphorylation"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0018105">
<property type="term" value="P:peptidyl-serine phosphorylation"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0018107">
<property type="term" value="P:peptidyl-threonine phosphorylation"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0045766">
<property type="term" value="P:positive regulation of angiogenesis"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0002663">
<property type="term" value="P:positive regulation of B cell tolerance induction"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:2000563">
<property type="term" value="P:positive regulation of CD4-positive, alpha-beta T cell proliferation"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0008284">
<property type="term" value="P:positive regulation of cell proliferation"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ProtInc"/>
</dbReference>
<dbReference type="GO" id="GO:0010634">
<property type="term" value="P:positive regulation of epithelial cell migration"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0010718">
<property type="term" value="P:positive regulation of epithelial to mesenchymal transition"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:1905007">
<property type="term" value="P:positive regulation of epithelial to mesenchymal transition involved in endocardial cushion formation"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0002053">
<property type="term" value="P:positive regulation of mesenchymal cell proliferation"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0051138">
<property type="term" value="P:positive regulation of NK T cell differentiation"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:2000379">
<property type="term" value="P:positive regulation of reactive oxygen species metabolic process"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0043415">
<property type="term" value="P:positive regulation of skeletal muscle tissue regeneration"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0048661">
<property type="term" value="P:positive regulation of smooth muscle cell proliferation"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0002666">
<property type="term" value="P:positive regulation of T cell tolerance induction"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0002651">
<property type="term" value="P:positive regulation of tolerance induction to self antigen"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0006468">
<property type="term" value="P:protein phosphorylation"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0006898">
<property type="term" value="P:receptor-mediated endocytosis"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0042127">
<property type="term" value="P:regulation of cell proliferation"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0010468">
<property type="term" value="P:regulation of gene expression"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0070723">
<property type="term" value="P:response to cholesterol"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0042493">
<property type="term" value="P:response to drug"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0043627">
<property type="term" value="P:response to estrogen"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0009749">
<property type="term" value="P:response to glucose"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0001666">
<property type="term" value="P:response to hypoxia"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0009612">
<property type="term" value="P:response to mechanical stimulus"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0007584">
<property type="term" value="P:response to nutrient"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0048545">
<property type="term" value="P:response to steroid hormone"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0007224">
<property type="term" value="P:smoothened signaling pathway"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0060440">
<property type="term" value="P:trachea formation"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0007179">
<property type="term" value="P:transforming growth factor beta receptor signaling pathway"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0003186">
<property type="term" value="P:tricuspid valve morphogenesis"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0001570">
<property type="term" value="P:vasculogenesis"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0060412">
<property type="term" value="P:ventricular septum morphogenesis"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0042060">
<property type="term" value="P:wound healing"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="InterPro" id="IPR011009">
<property type="entry name" value="Kinase-like_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR000719">
<property type="entry name" value="Prot_kinase_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR017441">
<property type="entry name" value="Protein_kinase_ATP_BS"/>
</dbReference>
<dbReference type="InterPro" id="IPR001245">
<property type="entry name" value="Ser-Thr/Tyr_kinase_cat_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR008271">
<property type="entry name" value="Ser/Thr_kinase_AS"/>
</dbReference>
<dbReference type="InterPro" id="IPR000333">
<property type="entry name" value="TGFB_receptor"/>
</dbReference>
<dbReference type="InterPro" id="IPR017194">
<property type="entry name" value="Transform_growth_fac-b_typ-2"/>
</dbReference>
<dbReference type="InterPro" id="IPR015013">
<property type="entry name" value="Transforming_GF_b_rcpt_2_ecto"/>
</dbReference>
<dbReference type="PANTHER" id="PTHR23255">
<property type="entry name" value="PTHR23255"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF08917">
<property type="entry name" value="ecTbetaR2"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF07714">
<property type="entry name" value="Pkinase_Tyr"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PIRSF" id="PIRSF037393">
<property type="entry name" value="TGFRII"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PRINTS" id="PR00653">
<property type="entry name" value="ACTIVIN2R"/>
</dbReference>
<dbReference type="SMART" id="SM00220">
<property type="entry name" value="S_TKc"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF56112">
<property type="entry name" value="SSF56112"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS00107">
<property type="entry name" value="PROTEIN_KINASE_ATP"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS50011">
<property type="entry name" value="PROTEIN_KINASE_DOM"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS00108">
<property type="entry name" value="PROTEIN_KINASE_ST"/>
<property type="match status" value="1"/>
</dbReference>
<proteinExistence type="evidence at protein level"/>
<keyword id="KW-0002">3D-structure</keyword>
<keyword id="KW-0025">Alternative splicing</keyword>
<keyword id="KW-0993">Aortic aneurysm</keyword>
<keyword id="KW-0053">Apoptosis</keyword>
<keyword id="KW-0067">ATP-binding</keyword>
<keyword id="KW-1003">Cell membrane</keyword>
<keyword id="KW-0181">Complete proteome</keyword>
<keyword id="KW-0221">Differentiation</keyword>
<keyword id="KW-0903">Direct protein sequencing</keyword>
<keyword id="KW-0225">Disease mutation</keyword>
<keyword id="KW-1015">Disulfide bond</keyword>
<keyword id="KW-0325">Glycoprotein</keyword>
<keyword id="KW-0341">Growth regulation</keyword>
<keyword id="KW-0362">Hereditary nonpolyposis colorectal cancer</keyword>
<keyword id="KW-0418">Kinase</keyword>
<keyword id="KW-0460">Magnesium</keyword>
<keyword id="KW-0464">Manganese</keyword>
<keyword id="KW-0472">Membrane</keyword>
<keyword id="KW-0479">Metal-binding</keyword>
<keyword id="KW-0547">Nucleotide-binding</keyword>
<keyword id="KW-0597">Phosphoprotein</keyword>
<keyword id="KW-0621">Polymorphism</keyword>
<keyword id="KW-0675">Receptor</keyword>
<keyword id="KW-1185">Reference proteome</keyword>
<keyword id="KW-0723">Serine/threonine-protein kinase</keyword>
<keyword id="KW-0732">Signal</keyword>
<keyword id="KW-0808">Transferase</keyword>
<keyword id="KW-0812">Transmembrane</keyword>
<keyword id="KW-1133">Transmembrane helix</keyword>
<feature type="signal peptide" evidence="23">
<location>
<begin position="1"/>
<end position="22"/>
</location>
</feature>
<feature type="chain" description="TGF-beta receptor type-2" id="PRO_0000024426">
<location>
<begin position="23"/>
<end position="567"/>
</location>
</feature>
<feature type="topological domain" description="Extracellular" evidence="10">
<location>
<begin position="23"/>
<end position="166"/>
</location>
</feature>
<feature type="transmembrane region" description="Helical" evidence="10">
<location>
<begin position="167"/>
<end position="187"/>
</location>
</feature>
<feature type="topological domain" description="Cytoplasmic" evidence="10">
<location>
<begin position="188"/>
<end position="567"/>
</location>
</feature>
<feature type="domain" description="Protein kinase" evidence="11">
<location>
<begin position="244"/>
<end position="544"/>
</location>
</feature>
<feature type="nucleotide phosphate-binding region" description="ATP" evidence="11">
<location>
<begin position="250"/>
<end position="258"/>
</location>
</feature>
<feature type="active site" description="Proton acceptor" evidence="11 12">
<location>
<position position="379"/>
</location>
</feature>
<feature type="binding site" description="ATP" evidence="11">
<location>
<position position="277"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="9">
<location>
<position position="409"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="5 6 7">
<location>
<position position="548"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="9">
<location>
<position position="553"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="10">
<location>
<position position="70"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="10">
<location>
<position position="94"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="10">
<location>
<position position="154"/>
</location>
</feature>
<feature type="disulfide bond" evidence="16 17 19 30 34">
<location>
<begin position="51"/>
<end position="84"/>
</location>
</feature>
<feature type="disulfide bond" evidence="16 17 19 30 34">
<location>
<begin position="54"/>
<end position="71"/>
</location>
</feature>
<feature type="disulfide bond" evidence="16 17 19 30 34">
<location>
<begin position="61"/>
<end position="67"/>
</location>
</feature>
<feature type="disulfide bond" evidence="16 17 19 30 34">
<location>
<begin position="77"/>
<end position="101"/>
</location>
</feature>
<feature type="disulfide bond" evidence="16 17 19 30 34">
<location>
<begin position="121"/>
<end position="136"/>
</location>
</feature>
<feature type="disulfide bond" evidence="16 17 19 30 34">
<location>
<begin position="138"/>
<end position="143"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 2." id="VSP_012157" evidence="47 48">
<original>SV</original>
<variation>SDVEMEAQKDEIICPSCNRTAHPLRHI</variation>
<location>
<begin position="31"/>
<end position="32"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs17025864." id="VAR_020510" evidence="46">
<original>M</original>
<variation>V</variation>
<location>
<position position="36"/>
</location>
</feature>
<feature type="sequence variant" description="In a gastric adenocarcinoma sample; somatic mutation." id="VAR_041414" evidence="29">
<original>C</original>
<variation>R</variation>
<location>
<position position="61"/>
</location>
</feature>
<feature type="sequence variant" description="In a colorectal cancer sample; somatic mutation." id="VAR_036070" evidence="27">
<original>I</original>
<variation>V</variation>
<location>
<position position="73"/>
</location>
</feature>
<feature type="sequence variant" description="In LDS2; dbSNP:rs780542125." id="VAR_076167" evidence="31">
<original>R</original>
<variation>H</variation>
<location>
<position position="190"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs56105708." id="VAR_017606" evidence="18 29">
<original>V</original>
<variation>I</variation>
<location>
<position position="191"/>
</location>
</feature>
<feature type="sequence variant" description="In LDS2; dbSNP:rs761231369." id="VAR_076168" evidence="31">
<original>D</original>
<variation>V</variation>
<location>
<position position="247"/>
</location>
</feature>
<feature type="sequence variant" description="In LDS2." id="VAR_066723" evidence="38">
<original>Q</original>
<variation>HE</variation>
<location>
<position position="306"/>
</location>
</feature>
<feature type="sequence variant" description="In LDS2; has a negative effect on TGF-beta signaling; dbSNP:rs28934568." id="VAR_022351" evidence="22 35">
<original>L</original>
<variation>P</variation>
<location>
<position position="308"/>
</location>
</feature>
<feature type="sequence variant" description="In HNPCC6; dbSNP:rs34833812." id="VAR_008156" evidence="29 44">
<original>T</original>
<variation>M</variation>
<location>
<position position="315"/>
</location>
</feature>
<feature type="sequence variant" description="In LDS2." id="VAR_076169" evidence="31">
<original>T</original>
<variation>P</variation>
<location>
<position position="325"/>
</location>
</feature>
<feature type="sequence variant" description="In a lung neuroendocrine carcinoma sample; somatic mutation." id="VAR_041415" evidence="29">
<original>H</original>
<variation>Y</variation>
<location>
<position position="328"/>
</location>
</feature>
<feature type="sequence variant" description="In LDS2; dbSNP:rs104893812." id="VAR_022352" evidence="24">
<original>Y</original>
<variation>N</variation>
<location>
<position position="336"/>
</location>
</feature>
<feature type="sequence variant" description="In LDS2; dbSNP:rs104893813." id="VAR_022353" evidence="24">
<original>A</original>
<variation>P</variation>
<location>
<position position="355"/>
</location>
</feature>
<feature type="sequence variant" description="In LDS2." id="VAR_076170" evidence="31">
<original>G</original>
<variation>R</variation>
<location>
<position position="357"/>
</location>
</feature>
<feature type="sequence variant" description="In LDS2; dbSNP:rs104893814." id="VAR_022354" evidence="24">
<original>G</original>
<variation>W</variation>
<location>
<position position="357"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs35719192." id="VAR_041416" evidence="29">
<original>M</original>
<variation>I</variation>
<location>
<position position="373"/>
</location>
</feature>
<feature type="sequence variant" description="In LDS2." id="VAR_066724" evidence="38">
<original>H</original>
<variation>R</variation>
<location>
<position position="377"/>
</location>
</feature>
<feature type="sequence variant" description="In a breast tumor; dbSNP:rs35766612." id="VAR_022355" evidence="14 29">
<original>V</original>
<variation>M</variation>
<location>
<position position="387"/>
</location>
</feature>
<feature type="sequence variant" description="In a breast tumor; signaling of TGF-beta significantly inhibited." id="VAR_022356" evidence="14">
<original>N</original>
<variation>S</variation>
<location>
<position position="435"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs1050833." id="VAR_028063" evidence="21 41 42 43">
<original>V</original>
<variation>A</variation>
<location>
<position position="439"/>
</location>
</feature>
<feature type="sequence variant" description="In LDS2." id="VAR_066725" evidence="26">
<original>D</original>
<variation>N</variation>
<location>
<position position="446"/>
</location>
</feature>
<feature type="sequence variant" description="In a breast tumor; signaling of TGF-beta significantly inhibited." id="VAR_022357" evidence="14">
<original>V</original>
<variation>A</variation>
<location>
<position position="447"/>
</location>
</feature>
<feature type="sequence variant" description="In LDS2; has a negative effect on TGF-beta signaling; dbSNP:rs104893807." id="VAR_022358" evidence="22 38">
<original>S</original>
<variation>F</variation>
<location>
<position position="449"/>
</location>
</feature>
<feature type="sequence variant" description="In a breast tumor; signaling of TGF-beta significantly inhibited." id="VAR_022359" evidence="14">
<original>L</original>
<variation>M</variation>
<location>
<position position="452"/>
</location>
</feature>
<feature type="sequence variant" description="In LDS2." id="VAR_066726" evidence="33">
<original>M</original>
<variation>K</variation>
<location>
<position position="457"/>
</location>
</feature>
<feature type="sequence variant" description="In LDS2; dbSNP:rs104893811." id="VAR_029760" evidence="25">
<original>R</original>
<variation>C</variation>
<location>
<position position="460"/>
</location>
</feature>
<feature type="sequence variant" description="In LDS2; dbSNP:rs104893816." id="VAR_029761" evidence="25">
<original>R</original>
<variation>H</variation>
<location>
<position position="460"/>
</location>
</feature>
<feature type="sequence variant" description="In a gastric adenocarcinoma sample; somatic mutation." id="VAR_041417" evidence="29">
<original>N</original>
<variation>S</variation>
<location>
<position position="490"/>
</location>
</feature>
<feature type="sequence variant" description="In LDS2; dbSNP:rs863223853." id="VAR_066727" evidence="37">
<original>G</original>
<variation>V</variation>
<location>
<position position="509"/>
</location>
</feature>
<feature type="sequence variant" description="In LDS2." id="VAR_066728" evidence="37">
<original>I</original>
<variation>F</variation>
<location>
<position position="510"/>
</location>
</feature>
<feature type="sequence variant" description="In LDS2." id="VAR_066729" evidence="32">
<original>I</original>
<variation>S</variation>
<location>
<position position="510"/>
</location>
</feature>
<feature type="sequence variant" description="In LDS2; dbSNP:rs193922664." id="VAR_066730" evidence="38">
<original>C</original>
<variation>R</variation>
<location>
<position position="514"/>
</location>
</feature>
<feature type="sequence variant" description="In LDS2." id="VAR_066731" evidence="35">
<original>W</original>
<variation>R</variation>
<location>
<position position="521"/>
</location>
</feature>
<feature type="sequence variant" description="In esophageal cancer; dbSNP:rs121918714." id="VAR_015816" evidence="13">
<original>E</original>
<variation>Q</variation>
<location>
<position position="526"/>
</location>
</feature>
<feature type="sequence variant" description="In LDS2; dbSNP:rs104893810." id="VAR_022360" evidence="24">
<original>R</original>
<variation>C</variation>
<location>
<position position="528"/>
</location>
</feature>
<feature type="sequence variant" description="In LDS2; dbSNP:rs104893815." id="VAR_022361" evidence="24 27">
<original>R</original>
<variation>H</variation>
<location>
<position position="528"/>
</location>
</feature>
<feature type="sequence variant" description="In LDS2." id="VAR_076171" evidence="31">
<original>T</original>
<variation>I</variation>
<location>
<position position="530"/>
</location>
</feature>
<feature type="sequence variant" description="In LDS2; has a negative effect on TGF-beta signaling; dbSNP:rs28934869." id="VAR_022362" evidence="22">
<original>R</original>
<variation>C</variation>
<location>
<position position="537"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolishes kinase activity, TGF-beta signaling and interaction with DAXX." evidence="15">
<original>K</original>
<variation>R</variation>
<location>
<position position="277"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 6; BAA09332." ref="6" evidence="49">
<original>K</original>
<variation>N</variation>
<location>
<position position="381"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="40"/>
<end position="45"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="50"/>
<end position="52"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="55"/>
<end position="58"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="65"/>
<end position="68"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="74"/>
<end position="76"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="78"/>
<end position="81"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="83"/>
<end position="90"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="95"/>
<end position="102"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="106"/>
<end position="110"/>
</location>
</feature>
<feature type="turn" evidence="1">
<location>
<begin position="114"/>
<end position="117"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="119"/>
<end position="122"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="124"/>
<end position="126"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="131"/>
<end position="138"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="140"/>
<end position="142"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="143"/>
<end position="145"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="146"/>
<end position="148"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="149"/>
<end position="154"/>
</location>
</feature>
<feature type="strand" evidence="4">
<location>
<begin position="244"/>
<end position="252"/>
</location>
</feature>
<feature type="strand" evidence="4">
<location>
<begin position="257"/>
<end position="263"/>
</location>
</feature>
<feature type="strand" evidence="4">
<location>
<begin position="273"/>
<end position="280"/>
</location>
</feature>
<feature type="helix" evidence="4">
<location>
<begin position="281"/>
<end position="283"/>
</location>
</feature>
<feature type="helix" evidence="4">
<location>
<begin position="284"/>
<end position="294"/>
</location>
</feature>
<feature type="helix" evidence="4">
<location>
<begin position="297"/>
<end position="299"/>
</location>
</feature>
<feature type="strand" evidence="4">
<location>
<begin position="307"/>
<end position="314"/>
</location>
</feature>
<feature type="strand" evidence="4">
<location>
<begin position="316"/>
<end position="326"/>
</location>
</feature>
<feature type="helix" evidence="4">
<location>
<begin position="333"/>
<end position="339"/>
</location>
</feature>
<feature type="helix" evidence="4">
<location>
<begin position="344"/>
<end position="362"/>
</location>
</feature>
<feature type="helix" evidence="4">
<location>
<begin position="382"/>
<end position="384"/>
</location>
</feature>
<feature type="strand" evidence="4">
<location>
<begin position="385"/>
<end position="387"/>
</location>
</feature>
<feature type="strand" evidence="4">
<location>
<begin position="393"/>
<end position="395"/>
</location>
</feature>
<feature type="turn" evidence="4">
<location>
<begin position="410"/>
<end position="414"/>
</location>
</feature>
<feature type="helix" evidence="4">
<location>
<begin position="422"/>
<end position="424"/>
</location>
</feature>
<feature type="helix" evidence="4">
<location>
<begin position="427"/>
<end position="430"/>
</location>
</feature>
<feature type="helix" evidence="4">
<location>
<begin position="439"/>
<end position="459"/>
</location>
</feature>
<feature type="helix" evidence="4">
<location>
<begin position="462"/>
<end position="464"/>
</location>
</feature>
<feature type="turn" evidence="4">
<location>
<begin position="473"/>
<end position="477"/>
</location>
</feature>
<feature type="helix" evidence="4">
<location>
<begin position="484"/>
<end position="491"/>
</location>
</feature>
<feature type="turn" evidence="4">
<location>
<begin position="492"/>
<end position="494"/>
</location>
</feature>
<feature type="helix" evidence="4">
<location>
<begin position="502"/>
<end position="506"/>
</location>
</feature>
<feature type="helix" evidence="4">
<location>
<begin position="508"/>
<end position="520"/>
</location>
</feature>
<feature type="helix" evidence="4">
<location>
<begin position="525"/>
<end position="527"/>
</location>
</feature>
<feature type="helix" evidence="4">
<location>
<begin position="531"/>
<end position="540"/>
</location>
</feature>
<evidence key="1" type="ECO:0000244">
<source>
<dbReference type="PDB" id="1M9Z"/>
</source>
</evidence>
<evidence key="2" type="ECO:0000244">
<source>
<dbReference type="PDB" id="1PLO"/>
</source>
</evidence>
<evidence key="3" type="ECO:0000244">
<source>
<dbReference type="PDB" id="3KFD"/>
</source>
</evidence>
<evidence key="4" type="ECO:0000244">
<source>
<dbReference type="PDB" id="5E8V"/>
</source>
</evidence>
<evidence key="5" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="18691976"/>
</source>
</evidence>
<evidence key="6" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="23186163"/>
</source>
</evidence>
<evidence key="7" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="24275569"/>
</source>
</evidence>
<evidence key="8" type="ECO:0000250"/>
<evidence key="9" type="ECO:0000250">
<source>
<dbReference type="UniProtKB" id="Q62312"/>
</source>
</evidence>
<evidence key="10" type="ECO:0000255"/>
<evidence key="11" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00159"/>
</source>
</evidence>
<evidence key="12" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU10027"/>
</source>
</evidence>
<evidence key="13" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10789724"/>
</source>
</evidence>
<evidence key="14" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11212236"/>
</source>
</evidence>
<evidence key="15" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11483955"/>
</source>
</evidence>
<evidence key="16" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11850637"/>
</source>
</evidence>
<evidence key="17" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12121646"/>
</source>
</evidence>
<evidence key="18" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12202987"/>
</source>
</evidence>
<evidence key="19" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12939140"/>
</source>
</evidence>
<evidence key="20" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12941698"/>
</source>
</evidence>
<evidence key="21" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="1310899"/>
</source>
</evidence>
<evidence key="22" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15235604"/>
</source>
</evidence>
<evidence key="23" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15340161"/>
</source>
</evidence>
<evidence key="24" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15731757"/>
</source>
</evidence>
<evidence key="25" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16027248"/>
</source>
</evidence>
<evidence key="26" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16251899"/>
</source>
</evidence>
<evidence key="27" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16959974"/>
</source>
</evidence>
<evidence key="28" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16982625"/>
</source>
</evidence>
<evidence key="29" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17344846"/>
</source>
</evidence>
<evidence key="30" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="18243111"/>
</source>
</evidence>
<evidence key="31" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19533785"/>
</source>
</evidence>
<evidence key="32" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19883511"/>
</source>
</evidence>
<evidence key="33" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="20101701"/>
</source>
</evidence>
<evidence key="34" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="20207738"/>
</source>
</evidence>
<evidence key="35" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="20358619"/>
</source>
</evidence>
<evidence key="36" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="21441952"/>
</source>
</evidence>
<evidence key="37" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="21949523"/>
</source>
</evidence>
<evidence key="38" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="22113417"/>
</source>
</evidence>
<evidence key="39" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="25893292"/>
</source>
</evidence>
<evidence key="40" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="7774578"/>
</source>
</evidence>
<evidence key="41" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="8812462"/>
</source>
</evidence>
<evidence key="42" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="8840968"/>
</source>
</evidence>
<evidence key="43" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="8973329"/>
</source>
</evidence>
<evidence key="44" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9590282"/>
</source>
</evidence>
<evidence key="45" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9865696"/>
</source>
</evidence>
<evidence key="46" type="ECO:0000269">
<source ref="7"/>
</evidence>
<evidence key="47" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="14702039"/>
</source>
</evidence>
<evidence key="48" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="7959019"/>
</source>
</evidence>
<evidence key="49" type="ECO:0000305"/>
<sequence length="567" mass="64568" checksum="C541DA751FFBDBEB" modified="2006-10-17" version="2" precursor="true">
MGRGLLRGLWPLHIVLWTRIASTIPPHVQKSVNNDMIVTDNNGAVKFPQLCKFCDVRFST
CDNQKSCMSNCSITSICEKPQEVCVAVWRKNDENITLETVCHDPKLPYHDFILEDAASPK
CIMKEKKKPGETFFMCSCSSDECNDNIIFSEEYNTSNPDLLLVIFQVTGISLLPPLGVAI
SVIIIFYCYRVNRQQKLSSTWETGKTRKLMEFSEHCAIILEDDRSDISSTCANNINHNTE
LLPIELDTLVGKGRFAEVYKAKLKQNTSEQFETVAVKIFPYEEYASWKTEKDIFSDINLK
HENILQFLTAEERKTELGKQYWLITAFHAKGNLQEYLTRHVISWEDLRKLGSSLARGIAH
LHSDHTPCGRPKMPIVHRDLKSSNILVKNDLTCCLCDFGLSLRLDPTLSVDDLANSGQVG
TARYMAPEVLESRMNLENVESFKQTDVYSMALVLWEMTSRCNAVGEVKDYEPPFGSKVRE
HPCVESMKDNVLRDRGRPEIPSFWLNHQGIQMVCETLTECWDHDPEARLTAQCVAERFSE
LEHLDRLSGRSCSEEKIPEDGSLNTTK
</sequence>
</entry>
<copyright>
Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
Distributed under the Creative Commons Attribution-NoDerivs License
</copyright>
</uniprot>